바이오테크 보도자료
-
- PMI Announces Medicago to Supply Up to 76 Million Doses of Its Plant-Derived COVID-19 Vaccine Candidate
- Since 2008, Philip Morris Investments B.V. (PMIBV), a subsidiary of Philip Morris International (PMI) (NYSE: PM), has been a shareholder of Medicago (in which it currently holds an approximately one-third equity stake) and has supported Medicago’s...
- 2020년 10월 26일
-
- JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma in Geneva, Switzerland
- JSR Life Sciences, LLC today announced that it is increasing its European footprint with a newly expanded, state-of-the-art facility that will co-locate primary European operations for its affiliate companies KBI Biopharma and Selexis SA. The two ...
- 2020년 10월 21일
-
- Vifor Pharma and Cara Therapeutics sign US license agreement for i.v. Korsuva™* to treat dialysis patients with pruritus
- Regulatory News: Vifor Pharma and Cara Therapeutics, Inc. (Nasdaq:CARA) today announced that both companies have signed a license agreement for commercialization of Korsuva (difelikefalin) Injection (“i.v. Korsuva”) for the treatment of chronic ki...
- 2020년 10월 21일
-
- Hypera Pharma Switches to Rimini Street Support for Its SAP Applications
- Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that Hypera Pharma, Brazil’...
- 2020년 10월 21일
-
- Prevailion Named a 2020 Gartner “Cool Vendor” in Security Operations and Threat Intelligence Field
- Prevailion, a global leader in cyber adversary intelligence, today announced that it has been recognized as a Gartner Cool Vendor in the latest Cool Vendors in Security Operations and Threat Intelligence report. The Gartner report profiles “emergi...
- 2020년 10월 20일
-
- Everbridge Features 43rd President of the United States George W. Bush Speaking on Leadership and Critical Event Management, as well as CNN’s Dr. Sanjay Gupta as Day 1 Keynote for COVID-19: Road to Recovery Symposium
- Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced highlights from day one of its two-day Autumn 2020 “COVID-19 R2R: The Road to Recovery” virtual leadership symposium, addressing global best pra...
- 2020년 10월 16일
-
- Waters ACQUITY PREMIER Columns Set a New Standard of Performance for Chromatographic Analyses
- Waters Corporation (NYSE:WAT) today introduced ACQUITY™ PREMIER Columns, a new family of premium sub-2-micron columns featuring MaxPeak™ High Performance Surface (HPS) technology. The columns are for use with any brand of UHPLC system and can meas...
- 2020년 10월 15일
-
- actnano, the Global Leader in Protective Nanocoatings for Automotive & Consumer Electronics, Raises an Oversubscribed $12M Series A Round
- Protective nanocoating company actnano today announced that it has raised $12M in a Series A funding round. Emerald Technology Ventures led the round and was joined by Material Impact, as well as Henkel Tech Ventures, GC Ventures America (PTT Glob...
- 2020년 10월 14일
-
- Takeda Accelerates Digital Transformation with Accenture and AWS
- Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) (“Takeda”), Accenture (NYSE: ACN) and Amazon Web Services, Inc. (AWS) have entered into a five-year strategic agreement to accelerate Takeda’s digital transformation. Not only will patien...
- 2020년 10월 14일
-
- Safety and Efficacy of Subcutaneous Entyvio® (Vedolizumab) Sustained During Long-term Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced interim results from the VISIBLE open-label extension (OLE) study on the long-term safety and efficacy of maintenance treatment with the subcutaneous (SC) formula...
- 2020년 10월 12일
-
- Galderma To Present Five Abstracts in Support of Novel Aesthetics Solutions and Pipeline at ASDS 2020 Annual Meeting
- Galderma today announced the presentation of data from clinical trials of its aesthetic solutions and pipeline in five abstracts at the virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting. The company also announced that i...
- 2020년 10월 12일
전시회
